The therapeutic programs of 23andMe include an antibody that restores the ability of the immune system to kill cancer cells.

Genetic-testing lab 23andMe plans to cut its workforce by 40% and end its therapeutics program in an effort to cut costs, the ...

DNA-testing company 23andMe said on Monday that it was firing roughly 40% of its workforce, more than 200 people, as Chief ...

DNA-testing company 23andMe Holding Co. will slash its workforce by about 40% and discontinue its therapeutics program as ...

The struggling genetic testing company 23andMe says it will cut 40% of its workforce, or 200 jobs, as it fights for survival.

(Reuters) -Genetic testing firm 23andMe said on Monday it is reducing about 40%, or 200 employees, from its workforce and ...

DNA commodification is no longer a future concern; it’s a present reality. Beyond charging users for their services, some ...

We remain deeply grateful to the patients, investigators and study staff for their participation in our clinical trials,” ...

However, 23andMe expects that these measures will eventually save them as much as $35 million. The company's CEO, Anne ...

23andMe, the genetics startup that has repeatedly captured the public imagination and then faced nearly fatal business ...

(GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (the “Company” or “23andMe”), a leading human genetics and preventive health company, today announced a business restructuring to streamline ...